Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Evan Osmundson

Dr. Evan Osmundson

Assistant Professor, Medical Director

Dr. Evan Osmundson is a radiation oncologist in Tennessee at Vanderbilt-Ingram Cancer Center with expertise in treating liver, lung and pleural mesothelioma cancers.

Get in touch
Jump to a Topic:

About Evan Osmundson

  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

  • 10+ Years of Experience icon

    10+ Years of Experience

  • Board Certified icon

    Board Certified in Radiation Oncology

  • Team Leader icon

    Team Leader

Dr. Evan Osmundson is part of the radiation oncology team at Vanderbilt-Ingram that uses state-of-the-art technology to fight cancer through a multidisciplinary approach to treatment.

Techniques include intensity modulated radiotherapy, stereotactic radiosurgery, brachytherapy and intraoperative radiation therapy, all with continuous review of patient treatment outcomes.

He works closely with pathologists, thoracic surgeons and medical oncologists, making sure patients receive the best possible care through a multimodal approach that is prioritized at Vanderbilt-Ingram.

“It’s very, very important, and essential, particularly in radiation oncology, where we rely heavily on imaging for our treatment planning,” Osmundson said. “It [a multidisciplinary approach] is absolutely essential in providing the best, individualized care.”

Involved in Collaborative Research

Osmundson is part of a lung cancer tumor board that meets weekly with the different specialists to devise the most effective strategy to treating individual patients.

He is also part of a radiation research team that has collaborated with renowned faculty from around the world in making advances to the field.

His research projects include genomic stress response and cell cycle control, among other topics.

Recent clinical research has involved the patterns of rare malignancies such as mesothelioma, Tumor Treating Fields and novel PET biomarkers.

Osmundson was the lead author in one study of stereotactic body radiation therapy and predictors of toxicity to the hepatobiliary tract. He co-authored another study involving the same radiation therapy and central liver toxicity.

Proud to be at Vanderbilt

Osmundson earned his medical degree from the University of Illinois, where he also received a Ph.D.

He received his Bachelor of Science degree from California State Polytechnic University.

In addition to treating mesothelioma, Osmundson’s specialties include liver and lung cancers. He also treats patients with head and neck cancers, along with upper-airway, oral, nasal and lip malignancies.

As a Designated Comprehensive Cancer Center by the National Cancer Institute, Vanderbilt-Ingram is among the leaders in innovation, treatment and research, attracting patients from across the state and beyond.

“At Vanderbilt, we have a large catchment area,” he said. “There are a lot of patients who come to Vanderbilt looking for that second opinion, or whose provider felt the case was complex enough to warrant our multidisciplinary expertise.”

Disclaimer: Dr. Evan Osmundson has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Walter Pacheco, Managing Editor at
Edited by

2 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Cure. (2017, November 17). What is a Multidisciplinary Tumor Board?
    Retrieved from:
  2. Vanderbilt Health. (n.d.). Evan C. Osmundson, MD, PhD. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified December 17, 2019

Get Your Free Mesothelioma Guide Chat live with a patient advocate now